Esperion Therapeutics, Inc. (ESPR) This fall 2025 Earnings Name March 10, 2026 8:00 AM EDT
Firm Individuals
Tiffany Aldrich – Affiliate Director of Company Communications
Sheldon Koenig – President, CEO & Director
Benjamin Halladay – Chief Monetary Officer
John Harlow – Chief Industrial Officer
Convention Name Individuals
Joseph Pantginis – H.C. Wainwright & Co, LLC, Analysis Division
Georgia Financial institution – Jefferies LLC, Analysis Division
Serge Belanger – Needham & Firm, LLC, Analysis Division
Jason Zemansky – BofA Securities, Analysis Division
David Amsellem – Piper Sandler & Co., Analysis Division
Kyuwon Choi – Goldman Sachs Group, Inc., Analysis Division
Presentation
Operator
Girls and gents, thanks for standing by, and welcome. (Operator Directions) Please be suggested that as we speak’s convention name will probably be recorded.
I might now like at hand the convention over to Tiffany Aldrich, Head of Company Communications for Esperion Therapeutics. Please go forward.
Tiffany Aldrich
Affiliate Director of Company Communications
Thanks, operator. Good morning, and welcome to Esperion’s Fourth Quarter and Full 12 months 2025 Earnings Convention Name. With us as we speak are Sheldon Koenig, President and CEO; and Ben Halladay, CFO. Different members of the manager workforce will probably be obtainable for Q&A following our ready remarks.
We issued a press launch earlier this morning detailing the content material of as we speak’s name. A duplicate will be discovered on the Investor web page of our web site, along with a replica of the presentation that we are going to even be referencing. I need to remind callers that the knowledge mentioned on the decision as we speak is roofed below the secure harbor provisions of the Personal Securities Litigation Reform Act. I warning listeners that administration will probably be making forward-looking statements. Precise outcomes may differ materially from these said or implied by our forward-looking statements as a consequence of dangers and uncertainties related to the enterprise.
These forward-looking statements